These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 16051786)
61. Recruiters and industry. Jackson M Nature; 2004 Mar; 428(6981):450. PubMed ID: 15042100 [No Abstract] [Full Text] [Related]
62. Drug discovery and natural products: end of an era or an endless frontier? Li JW; Vederas JC Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993 [TBL] [Abstract][Full Text] [Related]
63. Pharmaceutical aspects of combined vaccines: a manufacturer's perspective. Vose JR Biologicals; 1994 Dec; 22(4):335-8. PubMed ID: 7779359 [No Abstract] [Full Text] [Related]
64. Drug life-cycle technologies. Fleming E; Ma P Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253 [No Abstract] [Full Text] [Related]
65. Where is the optimism? Warrior teachings to regain the drug discovery spirit. Uitdehaag JC Drug Discov Today; 2007 Feb; 12(3-4):105-7. PubMed ID: 17275729 [No Abstract] [Full Text] [Related]
66. The difficulties industry is facing with investigators. Blackledge GR Eur J Cancer; 2005 Oct; 41(15):2210-2. PubMed ID: 16214043 [TBL] [Abstract][Full Text] [Related]
67. Boston means business for drug companies. Mervis J Science; 2005 Jul; 309(5735):723. PubMed ID: 16051782 [No Abstract] [Full Text] [Related]
68. Less is more: the human microdosing concept. Garner RC Drug Discov Today; 2005 Apr; 10(7):449-51. PubMed ID: 15809185 [No Abstract] [Full Text] [Related]
70. Lessons from 54 years of pharmaceutical research. Firestone RA Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986 [No Abstract] [Full Text] [Related]
71. Research on hire. Gupta AS Issues Med Ethics; 2001; 9(4):111-3. PubMed ID: 16334912 [No Abstract] [Full Text] [Related]
72. Drug discovery veers off target. Shaffer C Drug Discov Today; 2005 Nov; 10(22):1489. PubMed ID: 16257367 [TBL] [Abstract][Full Text] [Related]
73. A status report on neuroscience research, without grade inflation. Johnston SC; Hauser SL Ann Neurol; 2006 Dec; 60(6):A9-11. PubMed ID: 17192939 [No Abstract] [Full Text] [Related]
74. Enterprising drug company offers cash for chemicals. Adam D Nature; 2001 Aug; 412(6847):575. PubMed ID: 11493887 [No Abstract] [Full Text] [Related]
75. Clinical trial publications. Bhatt AD Issues Med Ethics; 2000; 8(4):119-21. PubMed ID: 16323375 [No Abstract] [Full Text] [Related]
76. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Peppercorn J; Blood E; Winer E; Partridge A Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054 [TBL] [Abstract][Full Text] [Related]
77. Medicine and the pharmaceutical industry. Baxter P Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771 [No Abstract] [Full Text] [Related]
78. Alternative business models for drug discovery. Bunin BA; Ekins S Drug Discov Today; 2011 Aug; 16(15-16):643-5. PubMed ID: 21745585 [No Abstract] [Full Text] [Related]
79. High-throughput drug discovery: what can we expect from HTS? Gribbon P; Sewing A Drug Discov Today; 2005 Jan; 10(1):17-22. PubMed ID: 15676295 [No Abstract] [Full Text] [Related]
80. Medicinal chemistry at a crossroads: challenges and new possibilities. Ojima I Future Med Chem; 2009 Jun; 1(3):401-3. PubMed ID: 21426118 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]